Literature DB >> 6307138

Pharmacology of ketoconazole suspension in infants and children.

C M Ginsburg, G H McCracken, K Olsen.   

Abstract

The pharmacokinetics of ketoconazole administered as either a commercially prepared suspension or as a crushed tablet in applesauce were studied in 12 children. The mean peak plasma concentration of ketoconazole and the area under the plasma time-concentration curve were approximately twofold greater with the suspension than with the crushed tablets.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6307138      PMCID： PMC184820          DOI： 10.1128/AAC.23.5.787

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  The influence of gastric acidity on the bio-availability of ketoconazole.

Authors:  J W Van Der Meer; J J Keuning; H W Scheijgrond; J Heykants; J Van Cutsem; J Brugmans
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

2.  Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazole.

Authors:  C Brass; J N Galgiani; S C Campbell; D A Stevens
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

3.  Ketoconazole treatment of chronic mucocutaneous candidiasis.

Authors:  J R Graybill; J H Herndon; W T Kniker; H B Levine
Journal:  Arch Dermatol       Date:  1980-10

4.  Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.

Authors:  D Dixon; S Shadomy; H J Shadomy; A Espinel-Ingroff; T M Kerkering
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226
  4 in total
  6 in total

Review 1.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

2.  Ketoconazole. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1985-12-01       Impact factor: 8.262

3.  Outbreak of Tinea capitis caused by Microsporum ferrugineum in Thailand.

Authors:  W Wisuthsarewong; A Chaiprasert; S Viravan
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

4.  Pharmacokinetics of ketoconazole and treatment evaluation in candidal infections.

Authors:  M Bardare; A M Tortorano; M C Pietrogrande; M A Viviani
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

Review 5.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

6.  Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics.

Authors:  Jeffry Adiwidjaja; Alan V Boddy; Andrew J McLachlan
Journal:  Front Pharmacol       Date:  2020-01-30       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.